表紙
市場調查報告書
商品編碼
1029046

全球電子臨床解決方案市場(~2026):階段,產品(CDMS,EDC,CTMS,eCOA,RTSM,ETMF,分析/集成/安全),部署類別(基於Web,按需/本地/雲端),最終用戶,地區

eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user(Pharma & Biotech, Hospitals, CROs) -Global Forecasts to 2026

出版日期: | 出版商: MarketsandMarkets | 英文 225 Pages | 訂單完成後即時交付

價格
  • 全貌
  • 簡介
  • 目錄
簡介

在預測期內,全球電子臨床解決方案市場預計將以 13.3% 的複合年增長率增長,從 2021 年的 83 億美元增長到 2026 年的 154 億美元。

由於與臨床研究相關的運營成本和監管要求增加、政府撥款支持臨床試驗以及製藥和生物技術公司藥物開發的研發成本增加等因素導致市場增長。

按部署類別劃分,網絡託管(按需)部門在 2020 年的份額最大。同時,在增長方面,基於雲的 (SaaS) 行業預計將在預測期內創下最高的複合年增長率。此外,按臨床試驗階段,預計第三階段部門將在預測期內顯示出最高增長。第三階段涉及數千名患者,預計對臨床解決方案的需求量很大。

本報告探討了電子臨床解決方案的全球市場、市場定義和概述、價值鏈、新型冠狀病毒感染 (COVID-19) 分析和其他市場影響因素、案例研究、市場。它總結了以下方面的變化和預測規模,按產品、部署類別、階段、最終用戶、地區/主要國家、競爭環境、主要公司簡介等各種類別進行細分。

目錄

第 1 章介紹

第二章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 市場動態
    • 市場增長因素
    • 市場製約因素
    • 增長機會
    • 市場問題
  • COVID-19 的影響
  • 生態系統
  • 案例研究
  • 價值鏈
  • 波特五力分析

第 6 章市場分析/預測:按產品

  • 電子數據採集/臨床數據管理系統
  • 臨床試驗管理系統
  • 臨床分析平台
  • 隨機和研究性藥物供應管理
  • 臨床數據集成平台
  • 電子臨床結果評估解決方案
  • 安全解決方案
  • 電子臨床試驗主文件系統
  • 監管信息管理解決方案
  • 其他

第 7 章市場分析/預測:按部署類別

  • 網絡託管(按需)解決方案
  • 許可公司(本地)解決方案
  • 基於雲 (SAAS) 的解決方案

第 8 章市場分析/預測:按階段

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第 9 章市場分析/預測:按最終用戶

  • 製藥公司/生物製藥公司
  • 首席風險官
  • 諮詢服務公司
  • 醫療器械製造商
  • 醫院
  • 學術研究機構

第 10 章市場分析/預測:按地區/主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 其他領域

第11章競爭形勢

  • 大公司的成功戰略
  • 主要公司的收入份額分析
  • 市場份額分析
  • 企業評估象限
  • 中小企業評估
  • 競爭基準
  • 競爭形勢/趨勢

第12章公司簡介

  • 主要公司
    • ORACLE CORPORATION.
    • DASSAULT SYSTEMES
    • PAREXEL INTERNATIONAL CORPORATION
    • BIOCLINICA, INC.
    • DATATRAK INTERNATIONAL, INC.
    • SIGNANT HEALTH(CRF HEALTH)
    • ERT CLINICAL
    • MAXISIT INC.
  • 其它有力企業
    • 4G CLINICAL
    • ECLINICAL SOLUTIONS LLC
    • VEEVA SYSTEMS
    • RESEARCH MANAGER
    • SAAMA TECHNOLOGIES
    • MEDNET
    • ANJU SOFTWARE
    • MEDRIO INC
    • CASTOR EDC
    • CLINPACE CLINICAL RESEARCH
    • IBM WATSON HEALTH
    • ARIS GLOBAL
    • QURETEC. LTD
    • OPENCLINICA
    • ADVARRA
    • REAL TIME SOFTWARE SOLUTIONS
    • YPRIME

第13章 附錄

目錄
Product Code: HIT 2208

The global eClinical Solutions market is projected to reach USD 15.4 billionby 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech companies are some of the major driving factors for the global eClinical solutions market.

Cloud-based (SaaS) segment is projected to record the highest CAGR

Based on delivery mode, the global eClinical solutions market is segmented into web-hosted (on-demand), licensed enterprise (on-premises), and cloud-based (SaaS) solutions. In 2020, the web-hosted (on-demand) segment commanded the largest share of the global eClinical solutions market. The increasing number of cloud-based clinical trial solutions in the market and the rising adoption of these solutions in clinical research studies (owing to advantages such as ease of integration, quicker deployment, and flexible scalability with a fixed monthly fee) are fueling the growth of the cloud-based eClinical solutions market.

Phase III clinical trials is expected to register the highest growth during the forecast period

Based on clinical trial phase, the eClinical solutions market has been segmented into phase I, phase II, phase III, and phase IV trials. The phase III clinical trials segment accounted for the largest share of the eClinical solutions market in 2020. The large share of this segment is attributed to the high demand for eClinical solutions for phase III trials due to the involvement of thousands of patients in this phase.

CROs segment is estimated to record the highest CAGR in the forecast period.

Based on end user, the global eClinical solutions market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions. The pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the eClinical solutions market in 2020. However, the CROs segment is estimated to record the highest CAGR (15.5%) in the next five years. The increasing number of CROs in developed as well as developing countries, and the rising instances of clinical trial outsourcing to specialized clinical research organizations are responsible for the high growth rate of this segment.

North America To Witness Significant Growth From 2021 To 2026

In 2020, North America commanded the largest share of the eClinical solutions market.Increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, and growth in the number of partnerships for new drug development are further stimulating the demand for eClinical solutions in this region.

Breakdown of supply-side primary interviews: * By Company Type: Tier 1 - 33%, Tier 2 - 42%, and Tier 3 - 18% * By Designation: C-level - 29%, Director-level - 23%, and Others - 48% * By Region: North America - 35%, Europe - 30%, APAC -26%, Rest of the World -9%

Some of the prominent players in this market are Oracle Corporation (US), Medidata Solutions, Inc. (US), Parexel International Corporation (US), BioClinica, Inc. (US), Signant Health (US), Datatrak International, Inc. (US), ERT (US), eClinical Solutions, Inc. (US), MaxisIT Inc. (US), Bio-Optronics, Inc. (US), Merge Healthcare Incorporated (US), and OmniComm Systems, Inc. (US)

Research Coverage

This report describes and studies the eClinical Solutions market based on product, delivery mode, clinical trials phases, end users and region. It provides detailed information regarding the major factors influencing the growth of this market and the factors impacting market dynamics. The report includes in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments (mergers, acquisitions, partnerships, collaborations, etc.), and key business strategies.

Key Benefits of Buying the Report

This report focuses on various levels of analysis-industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
    • 1.2.2 MARKETS COVERED
    • 1.2.3 GEOGRAPHIC SCOPE
    • 1.2.4 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 LIMITATIONS
  • 1.5 MAJOR MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • FIGURE 1 ECLINICAL SOLUTIONS MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Insights from primary experts
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION: ECLINICAL SOLUTIONS MARKET
    • FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 6 REVENUE ANALYSIS OF TOP 3 PUBLIC COMPANIES: ECLINICAL SOLUTIONS MARKET (2020)
    • FIGURE 7 BOTTOM-UP APPROACH
    • FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ECLINICAL SOLUTIONS MARKET (2021-2026)
    • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 10 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 ASSUMPTIONS FOR THE STUDY
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 1 RISK ASSESSMENT: ECLINICAL SOLUTIONS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 12 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 15 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 16 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2020 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 ECLINICAL SOLUTIONS: MARKET OVERVIEW
    • FIGURE 17 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING FORECAST PERIOD
  • 4.2 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE AND COUNTRY (2020)
    • FIGURE 18 WEB-HOSTED DELIVERY MODE DOMINATED ECLINICAL SOLUTIONS MARKET IN 2020
  • 4.3 ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2021 VS. 2026)
    • FIGURE 19 PHASE III CLINICAL TRIALS TO DOMINATE GLOBAL ECLINICAL SOLUTIONS MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 MAJOR MARKET DRIVERS
      • 5.2.1.1 Increasing operational costs and regulatory requirements associated with clinical research studies
      • 5.2.1.2 Growing adoption of novel software solutions in clinical research
      • 5.2.1.3 Increased government funding and grants to support clinical trials
      • 5.2.1.4 Need for improved data standardization
      • 5.2.1.5 Increasing R&D expenditure on drug development pipeline by pharma-biotech companies
      • 5.2.1.6 Growing customer base for eClinical solutions
    • TABLE 2 US: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED BETWEEN 2011 & 2015
    • 5.2.2 MAJOR MARKET RESTRAINTS
      • 5.2.2.1 High implementation costs associated with eClinical solutions
      • 5.2.2.2 Dearth of skilled professionals to operate eClinical solutions
      • 5.2.2.3 Limited awareness of advantages of eClinical solutions among researchers
    • 5.2.3 KEY GROWTH OPPORTUNITIES
      • 5.2.3.1 Increasing clinical research activities in emerging Asian countries
      • 5.2.3.2 Greater outsourcing of clinical trial processes to CROs
      • 5.2.3.3 Rising number of clinical trials in emerging countries
      • 5.2.3.4 Shift from manual data interpretation to real-time data analysis during clinical studies
    • 5.2.4 MAJOR MARKET CHALLENGES
      • 5.2.4.1 Limited adoption of eClinical solutions in developing nations
      • 5.2.4.2 Concerns about software reliability
      • 5.2.4.3 Patient privacy issues
  • 5.3 IMPACT OF COVID-19 ON THE ECLINICAL SOLUTIONS MARKET
  • 5.4 ECOSYSTEM ANALYSIS OF ECLINICAL SOLUTIONS MARKET
    • FIGURE 21 ECOSYSTEM ANALYSIS OF ECLINICAL SOLUTIONS MARKET
  • 5.5 CASE STUDIES
    • 5.5.1 YORK TEACHING HOSPITAL SPEEDS UP DATA CAPTURE PROCESS DURING PHASE III CLINICAL STUDY
    • 5.5.2 LSHTM AND MENAFRICAR USE DATA CAPTURE SOFTWARE TO STUDY MENINGOCOCCAL CARRIAGE IN AFRICAN MENINGITIS BELT
    • 5.5.3 CLINICAL TRIALS GROUP AT UCL USES EDC SYSTEM TO CAPTURE AND VERIFY PATIENT FEEDBACK
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 22 ECLINICAL SOLUTIONS : VALUE CHAIN
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 3 HIGH CAPITAL INVESTMENTS TO RESTRICT ENTRY OF NEW PLAYERS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF BUYERS
    • 5.7.4 BARGAINING POWER OF SUPPLIERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY

6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 4 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 5 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
  • 6.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
    • TABLE 6 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 7 NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 8 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 9 NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.3 CLINICAL TRIAL MANAGEMENT SYSTEMS
    • TABLE 10 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 11 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 12 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 13 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.4 CLINICAL ANALYTICS PLATFORMS
    • TABLE 14 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 15 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 16 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 17 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.5 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
    • TABLE 18 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 19 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 20 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 21 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.6 CLINICAL DATA INTEGRATION PLATFORMS
    • TABLE 22 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 23 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 24 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 25 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.7 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
    • TABLE 26 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 27 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 28 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 29 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.8 SAFETY SOLUTIONS
    • TABLE 30 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 31 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 32 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 33 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.9 ELECTRONIC TRIAL MASTER FILE SYSTEMS
    • TABLE 34 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 35 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 36 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 37 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.10 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
    • TABLE 38 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 39 NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 40 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 41 NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
  • 6.11 OTHER ECLINICAL SOLUTIONS
    • TABLE 42 GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 43 NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 44 GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 45 NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)

7 ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE

  • 7.1 INTRODUCTION
    • TABLE 46 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2015-2018 (USD MILLION)
    • TABLE 47 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2019-2026 (USD MILLION)
  • 7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
    • TABLE 48 WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 49 WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS
    • TABLE 50 LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 51 LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 CLOUD-BASED (SAAS) SOLUTIONS
    • TABLE 52 CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 53 CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)

8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE

  • 8.1 INTRODUCTION
    • FIGURE 23 PHASE III TRIALS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
    • TABLE 54 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 55 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
  • 8.2 PHASE I CLINICAL TRIALS
    • TABLE 56 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 57 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 PHASE II CLINICAL TRIALS
    • TABLE 58 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 59 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 PHASE III CLINICAL TRIALS
    • TABLE 60 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 61 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 PHASE IV CLINICAL TRIALS
    • TABLE 62 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 63 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2019-2026 (USD MILLION)

9 ECLINICAL SOLUTIONS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • FIGURE 24 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2020)
    • TABLE 64 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 65 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
    • TABLE 66 ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 67 ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS
    • TABLE 68 KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011-2015)
    • TABLE 69 ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 70 ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION, 2019-2026 (USD MILLION)
  • 9.4 CONSULTING SERVICE COMPANIES
    • TABLE 71 ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 72 ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2019-2026 (USD MILLION)
  • 9.5 MEDICAL DEVICE MANUFACTURERS
    • TABLE 73 ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 74 ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2019-2026 (USD MILLION)
  • 9.6 HOSPITALS
    • TABLE 75 ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 76 ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2019-2026 (USD MILLION)
  • 9.7 ACADEMIC RESEARCH INSTITUTES
    • TABLE 77 ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 78 ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)

10 ECLINICAL SOLUTIONS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2021 VS. 2026 (USD MILLION)
    • TABLE 79 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2018 (USD MILLION)
    • TABLE 80 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 26 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT
    • TABLE 81 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 82 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 83 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 84 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 85 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 86 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 87 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 88 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 89 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 90 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 Availability of government funding for clinical research to drive market growth
    • TABLE 91 US: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 92 US: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 93 US: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 94 US: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 95 US: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 96 US: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 97 US: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 98 US: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Government support to contribute to market growth
    • TABLE 99 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 100 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 101 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 102 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 103 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 104 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 105 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 106 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • FIGURE 27 EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT
    • TABLE 107 EMA-APPROVED BIOSIMILARS
    • TABLE 108 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 109 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 110 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 111 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 112 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 113 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 114 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 115 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 116 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018(USD MILLION)
    • TABLE 117 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Increasing R&D investments and initiatives to boost market growth
    • TABLE 118 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 119 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 120 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 121 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 122 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 123 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 124 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018(USD MILLION)
    • TABLE 125 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.2 UK
      • 10.3.2.1 Favorable R&D scenario to boost software adoption
    • TABLE 126 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 127 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 128 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 129 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 130 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 131 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 132 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018(USD MILLION)
    • TABLE 133 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 High number of oncology clinical trials to drive market growth
    • TABLE 134 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 135 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 136 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 137 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 138 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 139 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 140 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018(USD MILLION)
    • TABLE 141 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Low drug approval times drive growing adoption of eClinical solutions
    • TABLE 142 NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY, 2017
    • TABLE 143 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 144 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 145 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 146 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 147 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 148 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 149 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018(USD MILLION)
    • TABLE 150 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Rising R&D expenditure to propel market growth
    • TABLE 151 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 152 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 153 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 154 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 155 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 156 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 157 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018(USD MILLION)
    • TABLE 158 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 159 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 160 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 161 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 162 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 163 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 164 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 165 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018(USD MILLION)
    • TABLE 166 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
  • 10.4 ASIA-PACIFIC
    • FIGURE 28 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT
    • TABLE 167 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2018 (USD MILLION)
    • TABLE 168 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 169 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 170 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 171 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 172 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 173 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 174 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 175 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 176 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 CHINA
      • 10.4.1.1 Low cost of clinical trials and large pharmaceutical R&D base to drive market growth
    • TABLE 177 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 178 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 179 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 180 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 181 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 182 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 183 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 184 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Stringent regulatory scenario to restrain market growth
    • TABLE 185 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 186 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 187 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 188 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 189 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 190 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 191 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 192 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Favorable pharmaceutical R&D scenario to drive software adoption
    • TABLE 193 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 194 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 195 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 196 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 197 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 198 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 199 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 200 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC
    • TABLE 201 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 202 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 203 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 204 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 205 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 206 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 207 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 208 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • FIGURE 29 ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT
    • TABLE 209 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2018 (USD MILLION)
    • TABLE 210 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 211 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2018 (USD MILLION)
    • TABLE 212 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019-2026 (USD MILLION)
    • TABLE 213 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2018 (USD MILLION)
    • TABLE 214 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019-2026 (USD MILLION)
    • TABLE 215 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2018 (USD MILLION)
    • TABLE 216 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
    • FIGURE 30 ECLINICAL SOLUTIONS MARKET: STRATEGIES ADOPTED
  • 11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
    • FIGURE 31 KEY PLAYERS IN ECLINICAL SOLUTIONS MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 32 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2020
  • 11.5 COMPANY EVALUATION QUADRANT
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 33 ECLINICAL SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 11.6 ECLINICAL SOLUTIONS MARKET: SME EVALUATION
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 34 ECLINICAL SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR SMES, 2020
  • 11.7 COMPETITIVE BENCHMARKING
    • 11.7.1 COMPANY SERVICE FOOTPRINT (25 COMPANIES)
    • FIGURE 35 COMPANY PORTFOLIO FOOTPRINT: ECLINICAL SOLUTIONS MARKET
    • TABLE 217 COMPANY REGION FOOTPRINT (25 COMPANIES)
  • 11.8 COMPETITIVE SITUATIONS AND TRENDS
    • 11.8.1 PRODUCT/SERVICE LAUNCHES
    • TABLE 218 PRODUCT/SERVICE LAUNCHES (2018 TO 2021)
    • 11.8.2 DEALS
    • TABLE 219 DEALS
    • TABLE 220 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • (Business Overview, Products & services Offered, Recent Developments, and Right to win)**
  • 12.1 KEY PLAYERS
    • 12.1.1 ORACLE CORPORATION.
    • TABLE 221 ORACLE CORPORATION: BUSINESS OVERVIEW
    • FIGURE 36 ORACLE CORPORATION: COMPANY SNAPSHOT (2020)
    • 12.1.2 DASSAULT SYSTEMES
    • TABLE 222 DASSAULT SYSTEMES: BUSINESS OVERVIEW
    • FIGURE 37 DASSAULT SYSTEMES: COMPANY SNAPSHOT (2020)
    • 12.1.3 PAREXEL INTERNATIONAL CORPORATION
    • TABLE 223 PAREXEL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
    • 12.1.4 BIOCLINICA, INC. (SUBSIDIARY OF CINVEN)
    • TABLE 224 BIOCLINICA : BUSINESS OVERVIEW
    • 12.1.5 DATATRAK INTERNATIONAL, INC.
    • TABLE 225 DATATRAK INTERNATIONAL, INC: BUSINESS OVERVIEW
    • FIGURE 38 DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT (2020)
    • 12.1.6 SIGNANT HEALTH (CRF HEALTH)
    • TABLE 226 SIGNANT HEALTH : BUSINESS OVERVIEW
    • 12.1.7 ERT CLINICAL
    • TABLE 227 NELSON LABORATORIES: BUSINESS OVERVIEW
    • 12.1.8 MAXISIT INC.
    • TABLE 228 MAXISIT INC.: BUSINESS OVERVIEW
  • 12.2 OTHER PLAYERS
    • 12.2.1 4G CLINICAL
    • 12.2.2 ECLINICAL SOLUTIONS LLC
    • 12.2.3 VEEVA SYSTEMS
    • 12.2.4 RESEARCH MANAGER
    • 12.2.5 SAAMA TECHNOLOGIES
    • 12.2.6 MEDNET
    • 12.2.7 ANJU SOFTWARE (PORTFOLIO COMPANY OF ABRY PARTNERS)
    • 12.2.8 MEDRIO INC
    • 12.2.9 CASTOR EDC
    • 12.2.10 CLINPACE CLINICAL RESEARCH
    • 12.2.11 IBM WATSON HEALTH
    • 12.2.12 ARIS GLOBAL
    • 12.2.13 QURETEC. LTD
    • 12.2.14 OPENCLINICA
    • 12.2.15 ADVARRA
    • 12.2.16 REAL TIME SOFTWARE SOLUTIONS
    • 12.2.17 YPRIME
  • *Details on Business Overview, Products & services Offered, Recent Developments, and Right to win might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE**
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS